Synopsis
Synopsis
0
CEP/COS
0
VMF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 2-(1-azabicyclo(2.2.2)oct-3-yl)-2,3,3a,4,5,6-hexahydro-1h-benz(de)isoquinolin-1-one
2. 2-qhbiqo
3. Aloxi
4. Palonosetron
5. Palonosetron, (3r)-
6. Palonosetron, (r-(r*,r*))-isomer
7. Palonosetron, (r-(r*,s*))-isomer
8. Palonosetron, (s-(r*,s*))-isomer
9. Rs 25233 197
10. Rs 25233 198
11. Rs 25233-197
12. Rs 25233-198
13. Rs 25233197
14. Rs 25233198
15. Rs 25259
16. Rs 25259 197
17. Rs 25259 198
18. Rs 25259-197
19. Rs 25259-198
20. Rs 25259197
21. Rs 25259198
22. Rs-25233-197
23. Rs-25233-198
24. Rs-25259
25. Rs-25259-197
26. Rs-25259-198
27. Rs25233197
28. Rs25233198
29. Rs25259
30. Rs25259197
31. Rs25259198
1. 135729-62-3
2. Palonosetron Hcl
3. Aloxi
4. Onicit
5. Palonosetron (hydrochloride)
6. Rs-25259-197
7. (s,s)-palonosetron Hydrochloride
8. Palonocetron Hydrochloride
9. Palonosetron (as Hydrochloride)
10. Chebi:85157
11. Rs 25259-197
12. (3as)-2-(3s)-1-azabicyclo[2.2.2]oct-3-yl-2,3,3a,4,5,6-hexahydro-1h-benz[de]isoquinolin-1-one Monohydrochloride
13. (3as)-2-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-3a,4,5,6-tetrahydro-3h-benzo[de]isoquinolin-1-one;hydrochloride
14. 1h-benz[de]isoquinolin-1-one, 2-[(3s)-1-azabicyclo[2.2.2]oct-3-yl]-2,3,3a,4,5,6-hexahydro-, Hydrochloride (1:1), (3as)-
15. 23310d4i19
16. Aloxi (tn)
17. Dsstox_cid_26610
18. Dsstox_rid_81765
19. Dsstox_gsid_46610
20. (3as)-2,3,3a,4,5,6-hexahydro-2-((3s)-3-quinuclidinyl)-1h-benz(de)isoquinolin-1-one Monohydrochloride
21. (s)-2-((s)-quinuclidin-3-yl)-2,3,3a,4,5,6-hexahydro-1h-benzo[de]isoquinolin-1-one Hydrochloride
22. (r,s)-palonosetron Hcl
23. (s,r)-palonosetron Hcl
24. Cas-135729-62-3
25. Palonosetron Related Compound C
26. Palonosetron Related Compound D
27. Onicita
28. Paloxi
29. Palonosetron Hydrochloride [usan]
30. Unii-23310d4i19
31. Palonosetron Hydrochloride [usan:jan]
32. Palonosetronhydrochloride
33. Ncgc00166415-01
34. Chembl1720
35. Mls001424202
36. Schembl182478
37. Rs 25259 197
38. Dtxsid8046610
39. (3as)-palonosetron Hydrochloride
40. Palonosetron Hydrochloride- Bio-x
41. Palonosetron Hydrochloride (aloxi)
42. Ex-a4360
43. Hy-a0021
44. Tox21_112421
45. Mfcd00939524
46. Nsc743769
47. S3050
48. Palonosetron Hydrochloride (jan/usp)
49. Akos015895112
50. Akos026751493
51. Tox21_112421_1
52. Ac-1293
53. Ccg-101081
54. Ccg-221268
55. Cs-0621
56. Nc00331
57. Palonosetron Hydrochloride [mi]
58. Palonosetron Hydrochloride [jan]
59. Ncgc00166415-03
60. (3as)-2-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-3a,4,5,6-tetrahydro-3h-benzo[de]isoquinolin-1-one Hydrochloride
61. As-75066
62. Bp164227
63. Palonosetron Hydrochloride [mart.]
64. Rs 25259
65. Smr000469233
66. Palonosetron Hydrochloride [usp-rs]
67. Palonosetron Hydrochloride [who-dd]
68. Palonosetron Hydrochloride, >=98% (hplc)
69. P-225
70. P2051
71. Palonosetron Hydrochloride [ema Epar]
72. D05343
73. Palonosetron Hydrochloride [orange Book]
74. 729p623
75. Akynzeo Component Palonosetron Hydrochloride
76. Palonosetron Hydrochloride [usp Monograph]
77. 7-amino-3-(hydroxymethyl)-3-cephem-4-carboxylicacid
78. Palonosetron Hydrochloride Component Of Akynzeo
79. Q27158366
80. (s,r)-palonosetron Hydrochloride Contains Up To ~35% (r,r)-isomer
81. 1h-benz[de]isoquinolin-1-one,3,3a,4,5,6-hexahydro-, (3as)- Hydrochloride
82. 1h-benz[de]isoquinolin-1-one,3,3a,4,5,6-hexahydro-, [s-(r*,r*)]-, Hydrochloride
83. Palonosetron Hydrochloride, United States Pharmacopeia (usp) Reference Standard
84. (3as)-2-[(3s)-1-azabicyclo[2.2.2]oct-3-yl]-2,3,3a,4,5,6-hexahydro-1h-benz[de]isoquinolin-1-one Hydrochloride
85. (3as)-2-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-2,3,3a,4,5,6-hexahydro-1h-benzo[de]isoquinolin-1-one--hydrogen Chloride (1/1)
86. (3as)-2-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-3a,4,5,6-tetrahydro-3h-benzo[de]isoquinolin-1-one;hydrochloride.
87. (3as)-2-[(s)-1-azabicyclo[2.2.2]oct-3-yl]-2,3,3a,4,5,6-hexahydro-1-oxo-1h-benz[de]isoquinoline Hydrochloride
88. (3s)-3-[(3as)-1-oxo-3a,4,5,6-tetrahydro-1h-benzo[de]isoquinolin-2(3h)-yl]-1-azabicyclo[2.2.2]octan-1-ium Chloride
89. (5s)-3-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-3-azatricyclo[7.3.1.0?,(1)(3)]trideca-1(13),9,11-trien-2-one Hydrochloride
90. 1h-benz(de)isoquinolin-1-one, 2-(3s)-1-azabicyclo(2.2.2)oct-3-yl-2,3,3a,4,5,6-hexahydro-, Monohydrochloride, (3as)-
Molecular Weight | 332.9 g/mol |
---|---|
Molecular Formula | C19H25ClN2O |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 1 |
Exact Mass | 332.1655411 g/mol |
Monoisotopic Mass | 332.1655411 g/mol |
Topological Polar Surface Area | 23.6 Ų |
Heavy Atom Count | 23 |
Formal Charge | 0 |
Complexity | 456 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Palonosetron hydrochloride |
Drug Label | ALOXI (palonosetron hydrochloride) is an antiemetic and antinauseant agent. It is a serotonin-3 (5-HT3) receptor antagonist with a strong binding affinity for this receptor. Chemically, palonosetron hydrochloride is: (3aS)-2-[(S)-1-Azabicyclo [2.2.2]... |
Active Ingredient | Palonosetron hydrochloride |
Dosage Form | Injectable |
Route | injection |
Strength | 0.25mg/0.25ml; 0.25mg/5ml; 0.05mg/ml; 0.075mg/1.5ml |
Market Status | Tentative Approval |
Company | Teva Pharms; Dr Reddys Labs |
2 of 2 | |
---|---|
Drug Name | Palonosetron hydrochloride |
Drug Label | ALOXI (palonosetron hydrochloride) is an antiemetic and antinauseant agent. It is a serotonin-3 (5-HT3) receptor antagonist with a strong binding affinity for this receptor. Chemically, palonosetron hydrochloride is: (3aS)-2-[(S)-1-Azabicyclo [2.2.2]... |
Active Ingredient | Palonosetron hydrochloride |
Dosage Form | Injectable |
Route | injection |
Strength | 0.25mg/0.25ml; 0.25mg/5ml; 0.05mg/ml; 0.075mg/1.5ml |
Market Status | Tentative Approval |
Company | Teva Pharms; Dr Reddys Labs |
Aloxi is indicated in adults for:
- the prevention of acute nausea and vomiting associated with highly emetogenic cancer chemotherapy,
- the prevention of nausea and vomiting associated with moderately emetogenic cancer chemotherapy.
Aloxi is indicated in paediatric patients 1 month of age and older for:
- the prevention of acute nausea and vomiting associated with highly emetogenic cancer chemotherapy and prevention of nausea and vomiting associated with moderately emetogenic cancer chemotherapy.
Antiemetics
Drugs used to prevent NAUSEA or VOMITING. (See all compounds classified as Antiemetics.)
Serotonin 5-HT3 Receptor Antagonists
Drugs that bind to but do not activate SEROTONIN 5-HT3 RECEPTORS, thereby blocking the actions of SEROTONIN or SEROTONIN 5-HT3 RECEPTOR AGONISTS. (See all compounds classified as Serotonin 5-HT3 Receptor Antagonists.)
A04AA05
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
13
PharmaCompass offers a list of Palonosetron API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Palonosetron manufacturer or Palonosetron supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Palonosetron manufacturer or Palonosetron supplier.
PharmaCompass also assists you with knowing the Palonosetron API Price utilized in the formulation of products. Palonosetron API Price is not always fixed or binding as the Palonosetron Price is obtained through a variety of data sources. The Palonosetron Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Palonosetron HCl manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Palonosetron HCl, including repackagers and relabelers. The FDA regulates Palonosetron HCl manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Palonosetron HCl API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Palonosetron HCl manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Palonosetron HCl supplier is an individual or a company that provides Palonosetron HCl active pharmaceutical ingredient (API) or Palonosetron HCl finished formulations upon request. The Palonosetron HCl suppliers may include Palonosetron HCl API manufacturers, exporters, distributors and traders.
click here to find a list of Palonosetron HCl suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Palonosetron HCl DMF (Drug Master File) is a document detailing the whole manufacturing process of Palonosetron HCl active pharmaceutical ingredient (API) in detail. Different forms of Palonosetron HCl DMFs exist exist since differing nations have different regulations, such as Palonosetron HCl USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Palonosetron HCl DMF submitted to regulatory agencies in the US is known as a USDMF. Palonosetron HCl USDMF includes data on Palonosetron HCl's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Palonosetron HCl USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Palonosetron HCl suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Palonosetron HCl Drug Master File in Japan (Palonosetron HCl JDMF) empowers Palonosetron HCl API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Palonosetron HCl JDMF during the approval evaluation for pharmaceutical products. At the time of Palonosetron HCl JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Palonosetron HCl suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Palonosetron HCl Drug Master File in Korea (Palonosetron HCl KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Palonosetron HCl. The MFDS reviews the Palonosetron HCl KDMF as part of the drug registration process and uses the information provided in the Palonosetron HCl KDMF to evaluate the safety and efficacy of the drug.
After submitting a Palonosetron HCl KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Palonosetron HCl API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Palonosetron HCl suppliers with KDMF on PharmaCompass.
A Palonosetron HCl written confirmation (Palonosetron HCl WC) is an official document issued by a regulatory agency to a Palonosetron HCl manufacturer, verifying that the manufacturing facility of a Palonosetron HCl active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Palonosetron HCl APIs or Palonosetron HCl finished pharmaceutical products to another nation, regulatory agencies frequently require a Palonosetron HCl WC (written confirmation) as part of the regulatory process.
click here to find a list of Palonosetron HCl suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Palonosetron HCl as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Palonosetron HCl API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Palonosetron HCl as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Palonosetron HCl and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Palonosetron HCl NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Palonosetron HCl suppliers with NDC on PharmaCompass.
Palonosetron HCl Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Palonosetron HCl GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Palonosetron HCl GMP manufacturer or Palonosetron HCl GMP API supplier for your needs.
A Palonosetron HCl CoA (Certificate of Analysis) is a formal document that attests to Palonosetron HCl's compliance with Palonosetron HCl specifications and serves as a tool for batch-level quality control.
Palonosetron HCl CoA mostly includes findings from lab analyses of a specific batch. For each Palonosetron HCl CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Palonosetron HCl may be tested according to a variety of international standards, such as European Pharmacopoeia (Palonosetron HCl EP), Palonosetron HCl JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Palonosetron HCl USP).